MIM
LJPC

MetLife Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

MetLife Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,259
Closed -$116K – 2652
2018
Q4 		$116K Hold
12,259
– – ﹤0.01% 2230
2018
Q3 		$247K Hold
12,259
– – ﹤0.01% 1963
2018
Q2 		$358K Buy
12,259
+3,674
+43% +$113K ﹤0.01% 1624
2018
Q1 		$256K Hold
8,585
– – ﹤0.01% 1759
2017
Q4 		$276K Buy
+8,585
New +$281K ﹤0.01% 1758

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

MetLife Investment Management's LJPC Position: Q1 2019 in Review

MetLife Investment Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 12,259 shares — an estimated $116K sold.

MetLife Investment Management first reported a position in LJPC in Q4 2017 and held it in 5 quarters. The position peaked at $358K in Q2 2018. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

  • MetLife Investment Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
  • MetLife Investment Management sold 12,259 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $116K.
  • MetLife Investment Management first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 5 quarters.
  • MetLife Investment Management's La Jolla Pharmaceutical Company position peaked at $358K in Q2 2018.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on MetLife Investment Management's 13F filing for Q1 2019, filed 15 May 2019.